Barbed sutures having a therapeutic agent thereon
A barbed suture having a therapeutic agent.
1 . A barbed suture comprising a therapeutic agent.
2 . The suture of claim 1 having an outer surface, wherein the therapeutic agent contacts at least a portion of the outer surface of the suture.
3 . The suture of claim 1 having a first end portion, a second end portion and an intermediate portion, wherein the therapeutic agent contacts the intermediate portion of the suture.
4 . The suture of claim 3 wherein the therapeutic agent contacts only the intermediate portion of the suture.
5 . The suture of claim 3 wherein the first end portion comprises a first plurality of barbs facing a first direction, and the second end portion comprises a second plurality of barbs facing a second direction.
6 . The suture of claim 3 wherein the first end portion comprises a first plurality of barbs facing a first direction, and the second end portion comprises a second plurality of barbs facing the first direction.
7 . The suture of claim 3 wherein the therapeutic agent contacting the intermediate section is provided within a sheet contacting the intermediate section.
8 . The suture of claim 7 wherein the first and second end portions of the suture define a longitudinal axis, and the sheet is disposed in an orientation substantially normal to the longitudinal axis.
9 . The suture of claim 8 wherein the sheet comprises a material that loses rigidity when wetted.
10 . The suture of claim 1 wherein the therapeutic agent is a growth factor.
11 . The suture of claim 10 wherein the growth factor is a member of the BMP superfamily.
12 . The suture of claim 10 wherein the growth factor is a growth and differentiation factor (GDF).
13 . The suture of claim 1 wherein the therapeutic agent coats an entire length of the suture.
14 . The suture of claim 13 having a first end portion, a second end portion and an intermediate portion, wherein the therapeutic agent coats the intermediate portion of the suture at a first concentration and wherein the therapeutic agent coats the first and second end portions at a second concentration, wherein the first concentration in the intermediate portions is greater than the second concentration in the end portions.
15 . The suture of claim 1 wherein the therapeutic agent is provided in localized depots upon an outer surface of the suture.
16 . The suture of claim 15 wherein the depots comprised machined defects in the suture.
17 . A method of suturing, comprising the steps of:
a) providing a wound defect comprising a first and second tissue planes and a crevice therebetween,
b) providing a barbed suture having a first end portion, a second end portion and an intermediate portion comprising a therapeutic agent, and
c) inserting the first end of the suture into the first tissue plane and the second end portion of the suture into the second tissue plane so that the intermediate portion of the suture having the therapeutic agent thereon contacts the crevice.
18 . The method of claim 17 wherein the therapeutic agent contacts only the intermediate portion of the suture.
19 . The method of claim 17 wherein the first end portion comprises a first plurality of barbs facing a first direction, and the second end portion comprises a second plurality of barbs facing a second direction.
20 . The method of claim 19 wherein the therapeutic agent contacts only the intermediate portion of the suture.
21 . The method of claim 19 wherein the therapeutic agent contacting the intermediate section is provided within a sheet contacting the intermediate section.
22 . The method of claim 21 wherein the sheet is inserted into the crevice.
23 . The method of claim 17 wherein the therapeutic agent is a growth factor.
24 . The method of claim 23 wherein the growth factor is a member of the BMP superfamily.
25 . The method of claim 23 wherein the growth factor is a growth and differentiation factor (GDF).
26 . The method of claim 17 wherein the defect is an anterior cruciate ligament defect.
27 . The method of claim 26 wherein the therapeutic agent is a growth factor.
28 . The method of claim 27 wherein the growth factor is GDF-5.
29 . The method of claim 17 wherein the defect is a medial collateral ligament defect.
30 . The method of claim 29 wherein the therapeutic agent is a growth factor.
31 . The method of claim 30 wherein the growth factor is GDF-5.
32 . The method of claim 17 wherein the defect is a meniscal defect.
33 . The method of claim 32 wherein the therapeutic agent is a growth factor.
34 . The method of claim 33 wherein the growth factor is GDF-5.
35 . The method of claim 17 wherein the defect is a rotator cuff defect.
36 . The method of claim 35 wherein the therapeutic agent is a growth factor.
37 . The method of claim 36 wherein the growth factor is GDF-5.
38 . The method of claim 17 wherein the soft tissue is an annulus fibrosus of an intervertebral disc.
39 . The method of claim 38 wherein the therapeutic agent is a growth factor.
40 . The method of claim 39 wherein the growth factor is GDF-5.
41 . The method of claim 17 wherein the soft tissue is a ligament.
42 . The method of claim 41 wherein the therapeutic agent is a growth factor.
43 . The method of claim 42 wherein the growth factor is GDF-5.
44 . A device comprising:
i) a suture comprising an intermediate section and first and second end portions, and
ii) a sheet comprising a therapeutic agent, wherein the sheet contacts the intermediate section of the suture.
45 . The device of claim 44 wherein the first and second end portions of the suture define a longitudinal axis, and the sheet is disposed in an orientation substantially normal to the longitudinal axis.
46 . The device of claim 44 wherein the sheet comprises a material that loses rigidity when wetted.